Literature DB >> 32382742

Adipocyte Insulin Resistance in PCOS: Relationship With GLUT-4 Expression and Whole-Body Glucose Disposal and β-Cell Function.

Uche Ezeh1,2,3, Ida Y-D Chen2,4,5, Yen-Hao Chen2,3, Ricardo Azziz2,6,7,8.   

Abstract

CONTEXT: Impaired sensitivity to the antilipolytic action of insulin in adipose tissue (AT) may play a role in determining metabolic dysfunction in polycystic ovary syndrome (PCOS).
OBJECTIVES: To test the hypothesis that insulin resistance (IR) in AT is associated with whole-body insulin sensitivity and β-cell function in PCOS. RESEARCH DESIGN AND
SETTING: Prospective cross-sectional study.
METHODS: Eighteen participants with PCOS and 18-matched control participants underwent a modified frequently sampled intravenous glucose tolerance test (mFSIVGTT); subgroups underwent single-slice computed tomography scans determining AT distribution and adipocyte glucose transporter type 4 (GLUT-4) expression. MAIN OUTCOME MEASURES: IR in AT in basal (by the adipose insulin resistance index [Adipo-IR]) and dynamic (mFSIVGTT-derived indices of insulin-mediated nonesterified fatty acids [NEFA] suppression [NEFAnadir, TIMEnadir, and %NEFAsupp]) states; whole-body insulin-mediated glucose uptake and insulin secretion in basal (by homeostatic model assessment [HOMA]-IR and HOMA-β%) and dynamic (mFSIVGTT-derived insulin sensitivity index [Si], acute insulin response to glucose [AIRg], and disposition index [Di]) states.
RESULTS: Participants with PCOS had higher HOMA-IR and HOMA-β%, lower Si and Di, higher longer TIMEnadir, higher Adipo-IR and NEFAnadir, and a trend toward lower GLUT-4, than the control group participants. Adipo-IR was associated with dynamic state IR in AT (NEFAnadir TIMEnadir, and %NEFAsupp), but only in PCOS, and with HOMA-IR and HOMA-β% in both groups. NEFAnadir and TIMEnadir were negatively and %NEFAsupp positively associated with Si only in PCOS, but not with AIRg and Di, or GLUT-4 expression.
CONCLUSION: Women with PCOS demonstrated increased IR in AT, which is closely associated with whole-body IR but not with dynamic state β-cell function or adipocyte GLUT-4 gene expression. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Adipocyte; GLUT-4; PCOS; fatty acids; insulin resistance; β-cell function

Mesh:

Substances:

Year:  2020        PMID: 32382742      PMCID: PMC7274487          DOI: 10.1210/clinem/dgaa235

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  67 in total

1.  A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance.

Authors:  Ingvar Ek; Peter Arner; Mikael Rydén; Cecilia Holm; Anders Thörne; Johan Hoffstedt; Hans Wahrenberg
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

2.  Adipose Insulin Resistance in Obese Adolescents Across the Spectrum of Glucose Tolerance.

Authors:  Karen Hershkop; Omri Besor; Nicola Santoro; Bridget Pierpont; Sonia Caprio; Ram Weiss
Journal:  J Clin Endocrinol Metab       Date:  2016-04-07       Impact factor: 5.958

3.  Association of NEFA composition with insulin sensitivity and beta cell function in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort.

Authors:  Luke W Johnston; Stewart B Harris; Ravi Retnakaran; Adria Giacca; Zhen Liu; Richard P Bazinet; Anthony J Hanley
Journal:  Diabetologia       Date:  2017-12-24       Impact factor: 10.122

Review 4.  Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids.

Authors:  U Smith; B B Kahn
Journal:  J Intern Med       Date:  2016-10-03       Impact factor: 8.989

5.  Testosterone increases lipolysis and the number of beta-adrenoceptors in male rat adipocytes.

Authors:  X F Xu; G De Pergola; P Björntorp
Journal:  Endocrinology       Date:  1991-01       Impact factor: 4.736

6.  Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome.

Authors:  Andréanne Trottier; Marie-Claude Battista; David H Geller; Brigitte Moreau; André C Carpentier; Judith Simoneau-Roy; Jean-Patrice Baillargeon
Journal:  Fertil Steril       Date:  2012-09-15       Impact factor: 7.329

7.  Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.

Authors:  D A Ehrmann; J Sturis; M M Byrne; T Karrison; R L Rosenfield; K S Polonsky
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.

Authors:  E S Knochenhauer; T J Key; M Kahsar-Miller; W Waggoner; L R Boots; R Azziz
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

Review 9.  Fatty acids, obesity, and insulin resistance: time for a reevaluation.

Authors:  Fredrik Karpe; Julian R Dickmann; Keith N Frayn
Journal:  Diabetes       Date:  2011-10       Impact factor: 9.461

10.  Discovery of Novel Lipid Profiles in PCOS: Do Insulin and Androgen Oppositely Regulate Bioactive Lipid Production?

Authors:  Shengxian Li; Qianqian Chu; Jing Ma; Yun Sun; Tao Tao; Rong Huang; Yu Liao; Jiang Yue; Jun Zheng; Lihua Wang; Xinli Xue; Mingjiang Zhu; Xiaonan Kang; Huiyong Yin; Wei Liu
Journal:  J Clin Endocrinol Metab       Date:  2017-03-01       Impact factor: 5.958

View more
  5 in total

1.  The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS.

Authors:  Xiaojia Li; Dongyong Yang; Ping Pan; Ricardo Azziz; Dongzi Yang; Yanxiang Cheng; Xiaomiao Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-13       Impact factor: 6.055

2.  Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome.

Authors:  U Ezeh; M D Pisarska; R Azziz
Journal:  Hum Reprod       Date:  2022-03-01       Impact factor: 6.918

Review 3.  Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19.

Authors:  Ioannis Ilias; Spyridon Goulas; Lina Zabuliene
Journal:  World J Clin Cases       Date:  2021-04-26       Impact factor: 1.337

4.  Transcription Coactivator BCL3 Acts as a Potential Regulator of Lipid Metabolism Through the Effects on Inflammation.

Authors:  Shuo Zhang; Jingtao Gao; Shibo Liu; Lu Yu; Wen Zhang; Yinming Liang; Hui Wang
Journal:  J Inflamm Res       Date:  2021-09-23

Review 5.  Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport.

Authors:  Rok Herman; Nika Aleksandra Kravos; Mojca Jensterle; Andrej Janež; Vita Dolžan
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.